NCT05263999 · Interventional trial
A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR)
Overall registry status Terminated
Phase 3
Conditions Acute GVHD, Acute-graft-versus-host Disease, GVHD, Graft Versus Host Disease, aGVHD
Delaware Valley sites
- University of Pennsylvania Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory